By Moira Estrada
Shoppers scanning the frozen-food aisle now see a new promise on some boxes: “GLP-1 Friendly.” The label has started to show up as more Americans use powerful obesity drugs such as Wegovy and Zepbound, and food companies try to sell meals and snacks that fit smaller appetites and a focus on protein and fiber.
GLP-1 stands for glucagon-like peptide-1, a naturally occurring hormone the body releases in the gut after eating. It helps regulate blood sugar and digestion and influences appetite. Many of today’s leading obesity medicines act on the GLP-1 pathway, which can leave patients feeling full sooner and eating fewer calories overall.
A KFF Health Tracking Poll published Nov. 14, 2025, found that about one in eight U.S. adults, or 12%, said they currently take a GLP-1 drug for weight loss, diabetes or another condition. Federal regulators have expanded the category in recent years. The Food and Drug Administration approved Eli Lilly’s Zepbound (tirzepatide) for chronic weight management on Nov. 8, 2023, for adults with obesity or adults who are overweight with at least one weight-related condition, alongside diet and exercise.
Food companies have responded with product lines and marketing that call out the drugs by name — even though the government does not set a formal nutrition definition for “GLP-1 friendly,” according to dietitians and industry statements reported by The Associated Press.
Conagra Brands announced on Dec. 12, 2024, that it would add an “On Track” badge to 26 Healthy Choice frozen meals starting in January 2025, describing those items as “GLP-1 friendly” and highlighting protein, calorie and fiber information on the front of the package. Nestlé, meanwhile, introduced its Vital Pursuit frozen-meal line on May 21, 2024, pitching it as a companion for people using GLP-1 weight-loss medications and others pursuing weight management, with products positioned around protein, fiber and portion size.
Restaurants have jumped in, too. Smoothie King said on Oct. 29, 2024, that it launched a “GLP-1 Support Menu” featuring smoothies with at least 20 grams of protein, along with fiber and no added sugar, and that it worked with a registered dietitian on the rollout. Chipotle Mexican Grill announced on Dec. 18, 2025, that it would debut a “High Protein Menu” on Dec. 23, 2025, in the U.S. and Canada, with items the company said range from 15 to 81 grams of protein, including a new “High Protein Cup.”
Dietitians who work with patients taking GLP-1 medications say the basic nutrition goals do not differ much from what they recommend for most adults: prioritize balanced meals, choose nutrient-dense foods and pay attention to label details. What changes for many patients involves volume. The drugs can reduce appetite, so people may need to make fewer bites count.
Protein often tops the list because rapid weight loss can also reduce lean muscle mass, dietitians told the AP. Fiber matters because constipation ranks among common complaints with this class of drugs, and fiber also supports overall digestive health. Hydration also plays a role. One dietitian interviewed by the AP said some patients struggle to notice thirst cues while taking GLP-1 medications and may need to drink water more intentionally and rely on water-rich foods such as fruits and vegetables.
The marketing label, however, can mask tradeoffs. Dietitians told the AP that some products promoted for GLP-1 users still carry high amounts of saturated fat or sodium, which can undermine broader health goals. They urged consumers to check Nutrition Facts panels and ingredient lists instead of relying on front-of-pack wording.
The label itself also occupies a gray area. The Associated Press reported that Conagra and Nestlé received approval from the U.S. Department of Agriculture’s Food Safety and Inspection Service to use “GLP-1 Friendly” on certain products because the claims appear alongside statements about protein and fiber content and do not mislead consumers. The USDA also reiterated that no regulatory standard exists for the term.
That leaves consumers with a familiar assignment: read closely. Dietitians commonly advise people taking GLP-1 drugs to aim for adequate protein spread across meals, choose fiber sources that they tolerate well and watch sodium and saturated fat totals, especially if they also manage high blood pressure, high cholesterol or diabetes. Food companies say they see a growing market as drugmakers expand supply and develop new formulations, while dietitians say shoppers should treat “GLP-1 friendly” as marketing language — and let the nutrition label do the talking.
Original article
Comments